Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123602705 | 12360270 | 5 | F | 20160701 | 20160512 | 20160713 | PER | US-PFIZER INC-2016246147 | PFIZER | 71.00 | YR | M | Y | 68.00000 | KG | 20160713 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123602705 | 12360270 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 123602705 | 12360270 | 2 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 123602705 | 12360270 | 3 | C | GLIPIZIDE. | GLIPIZIDE | 1 | UNK | 0 | |||||||||||
| 123602705 | 12360270 | 4 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | UNK | 0 | |||||||||||
| 123602705 | 12360270 | 5 | C | METOPROLOL. | METOPROLOL | 1 | UNK | 0 | |||||||||||
| 123602705 | 12360270 | 6 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK | 0 | |||||||||||
| 123602705 | 12360270 | 7 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 123602705 | 12360270 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 123602705 | 12360270 | 9 | C | NYSTATIN. | NYSTATIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123602705 | 12360270 | 1 | Renal cancer stage IV |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123602705 | 12360270 | Arthralgia | |
| 123602705 | 12360270 | Asthenia | |
| 123602705 | 12360270 | Disease progression | |
| 123602705 | 12360270 | Fatigue | |
| 123602705 | 12360270 | Gait disturbance | |
| 123602705 | 12360270 | Hypersomnia | |
| 123602705 | 12360270 | Hypophagia | |
| 123602705 | 12360270 | Malaise | |
| 123602705 | 12360270 | Renal cancer stage IV | |
| 123602705 | 12360270 | Stomatitis | |
| 123602705 | 12360270 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123602705 | 12360270 | 1 | 20160426 | 20160523 | 0 |